You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Plasmodium falciparum malaria

Showing 1 - 25 of 1,382
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Uncomplicated Plasmodium Falciparum Malaria Trial (INE963, KAE609, SoC (Coartem))

Not yet recruiting
  • Uncomplicated Plasmodium Falciparum Malaria
  • (no location specified)
Feb 17, 2023

Malaria Trial (Meplazumab for Injection)

Not yet recruiting
  • Malaria
  • Meplazumab for Injection
  • (no location specified)
Sep 13, 2023

Uncomplicated Plasmodium Falciparum Malaria Trial (KLU156, Coartem)

Not yet recruiting
  • Uncomplicated Plasmodium Falciparum Malaria
  • (no location specified)
May 3, 2023

Malaria, Plasmodium Falciparum Trial in Oxford (Pfs48/45 in Matrix-M)

Recruiting
  • Malaria
  • Plasmodium Falciparum
  • Pfs48/45 in Matrix-M
  • Oxford, United Kingdom
    CCVTM, University of Oxford
Dec 13, 2022

TES of Artemether-lumefantrine for Pf in Philippines in

Completed
  • Malaria,Falciparum
  • Malaria Recrudescence
  • (no location specified)
Jul 20, 2023

Uncomplicated Plasmodium Falciparum Malaria Trial in Bagamoyo (Artemether-lumefantrine and Amodiaquine Drug Combination,

Not yet recruiting
  • Uncomplicated Plasmodium Falciparum Malaria
  • Artemether-lumefantrine and Amodiaquine Drug Combination
  • +2 more
  • Bagamoyo, Dar esSalaam, Tanzania
  • +1 more
Feb 28, 2023

Uncomplicated Plasmodium Falciparum Malaria Trial (Artemether-Lumefantrine-Amodiaquine (ALAQ), Artemether-Lumefantrine (AL),

Not yet recruiting
  • Uncomplicated Plasmodium Falciparum Malaria
  • Artemether-Lumefantrine-Amodiaquine (ALAQ)
  • +2 more
  • (no location specified)
Jul 20, 2023

TES of Artemether-lumefantrine for Pf in the Philippines in 2015

Completed
  • Malaria,Falciparum
  • Malaria Recrudescence
  • (no location specified)
Jul 20, 2023

Plasmodium Falciparum Malaria Trial in Bandarban, Lama (DHA/piperaquine and a SLD-PQ, Study vaccine R21/Matrix-M™)

Not yet recruiting
  • Plasmodium Falciparum Malaria
  • DHA/piperaquine and a SLD-PQ
  • Study vaccine R21/Matrix-M™
  • Bāndarban, Bangladesh
  • +1 more
Sep 28, 2023

Uncomplicated Plasmodium Falciparum Trial in Tambolaka (Dihydroartemisinin, Piperaquine, Primaquine)

Completed
  • Uncomplicated Plasmodium Falciparum
  • Tambolaka, East Nusa Tenggara, Indonesia
    Kori Puskesmas
Apr 27, 2023

Malaria,Falciparum, Malaria, Vivax, Malaria Trial in Manokwari (Dihydroartemisinin, Piperaquine, Primaquine)

Completed
  • Malaria,Falciparum
  • +5 more
  • Manokwari, West Papua, Indonesia
    Manokwari Regional General Hospital
Sep 11, 2023

Plasmodium Falciparum Malaria Trial in Burkina Faso, Congo, The Democratic Republic of the, Mali (artemether:lumefantrine (2.5

Recruiting
  • Plasmodium Falciparum Malaria
  • artemether:lumefantrine (2.5 mg:30 mg)
  • Nanoro, Burkina Faso
  • +5 more
Nov 28, 2022

Malaria Infection Trial in Darmstadt (M5717 60 mg, Pyronaridine, Atovaquone-Proguanil)

Not yet recruiting
  • Malaria Infection
  • M5717 60 mg
  • +4 more
  • Darmstadt, Germany
    Research Site
Aug 2, 2023

Uncomplicated Plasmodium Falciparum Malaria Trial in Congo, The Democratic Republic of the (Artesunate-amodiaquine,

Recruiting
  • Uncomplicated Plasmodium Falciparum Malaria
  • Kapolowe, Haut-Katanga, Congo, The Democratic Republic of the
  • +7 more
Oct 7, 2023

Malaria, Plasmodium Falciparum Trial in Bagamoyo (P. falciparum infected erythrocytes)

Not yet recruiting
  • Malaria
  • Plasmodium Falciparum
  • P. falciparum infected erythrocytes
  • Bagamoyo, Tanzania
    Ifakara Health Institute
May 26, 2022

Uncomplicated Plasmodium Falciparum Malaria Trial in Burkina Faso, Gabon, Mali (KAF156, LUM-SDF)

Recruiting
  • Uncomplicated Plasmodium Falciparum Malaria
  • Bobo Dioulasso, Burkina Faso
  • +4 more
Jun 20, 2022

Acute Malaria Trial in Worldwide (M5717 330 mg, M5717 500 mg, M5717 660 mg)

Not yet recruiting
  • Acute Malaria
  • M5717 330 mg
  • +8 more
  • Nanoro, Burkina Faso
  • +4 more
Jan 9, 2023

Malaria, Plasmodium Falciparum Trial (Matrix-M with RH5.2 VLP and/or R21)

Not yet recruiting
  • Malaria, Plasmodium Falciparum
  • Matrix-M with RH5.2 VLP and/or R21
  • (no location specified)
Oct 21, 2022

Severe Malaria Trial in Worldwide (KAE609, IV Artesunate, Coartem)

Recruiting
  • Severe Malaria
  • Kinsasha, Democratic Republic Of Congo, Congo
  • +6 more
Sep 23, 2022

Uncomplicated Plasmodium Falciparum Malaria Trial in Busia, Tororo (Artemether-lumefantrine)

Completed
  • Uncomplicated Plasmodium Falciparum Malaria
  • Busia, Uganda
  • +1 more
Oct 20, 2022

Malaria,Falciparum Trial in Kilifi (PfSPZ Challenge, Sulfadoxine-Pyrimethamine, Piperaquine)

Not yet recruiting
  • Malaria,Falciparum
  • PfSPZ Challenge
  • +4 more
  • Kilifi, Kenya
    KEMRI-Wellcome Trust Research Programme
May 17, 2022

Uncomplicated Malaria, Asymptomatic Condition, Falciparum Malaria Trial (ZY19489 + Ferroquine (FQ), Placebo)

Not yet recruiting
  • Uncomplicated Malaria
  • +2 more
  • ZY19489 + Ferroquine (FQ)
  • Placebo
  • (no location specified)
Jun 18, 2023

Malaria,Falciparum Trial (Artemisia afra or Annua 10g oral infusion/tea per day for 14 days)

Not yet recruiting
  • Malaria,Falciparum
  • Artemisia afra or Annua 10g oral infusion/tea per day for 14 days
  • (no location specified)
Mar 23, 2023

Acute Uncomplicated Plasmodium Falciparum Malaria Trial in Worldwide (KAF156, Coartem, Lumefantrine Solid Dispersion

Completed
Has Results
  • Acute Uncomplicated Plasmodium Falciparum Malaria
  • Nanoro, Burkina Faso
  • +10 more
Dec 21, 2021

Malaria,Falciparum Trial in Bagamoyo (RH5.1/Matrix-M)

Enrolling by invitation
  • Malaria,Falciparum
  • RH5.1/Matrix-M
  • Bagamoyo, Tanzania
    Ifakara Health Institute Clinical Trial Facility
Oct 21, 2022